| Literature DB >> 35685259 |
Makiko Nakamura1, Teruhiko Imamura1, Yuki Hida1, Akira Oshima1, Shigeki Yokoyama2, Toshio Doi2, Kazuaki Fukahara2, Koichiro Kinugawa1.
Abstract
The concept and therapeutic strategy for chronic lymphocytic myocarditis remain unestablished. We had a 57-year-old man with advanced biventricular (predominantly right ventricular) failure due to chronic lymphocytic myocarditis. He received central extracorporeal membrane oxygenation therapy that was explanted on day 129 following the aggressive steroid pulse and plasma exchange therapy. Infiltration of inflammatory cells persisted even after the device removal, which required long-term oral steroid administration after the index discharge on day 200. High-sensitivity cardiac troponin T level was normalized and inflammatory cell infiltration was remitted following post-discharge 4-month 10 mg/day prednisolone therapy. Aggressive immunosuppressive therapy under mechanical circulatory support might be a promising strategy for those with chronic lymphocytic myocarditis. <Learning objective: "Chronic myocarditis" does not exist as a formal classification of myocarditis worldwide and therapeutic strategy remains controversial. Aggressive immunosuppressive therapy under mechanical circulatory support might be a promising strategy for chronic lymphocytic myocarditis.>.Entities:
Keywords: Corticosteroids; Mechanical circulatory support; Unloading
Year: 2021 PMID: 35685259 PMCID: PMC9169008 DOI: 10.1016/j.jccase.2021.12.005
Source DB: PubMed Journal: J Cardiol Cases ISSN: 1878-5409